FDA Clearance Tracker · P240011
Medtronic Altaviva System
Last checked: Nov 19, 2026Latest source record: Sep 18, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Sep 18, 2025
Approved
Time to decision
532 days
Received Apr 4, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P240011
- Device name
- Medtronic Altaviva System
- Applicant
- Medtronic Neuromodulation
- Applicant location
- Minneapolis, MN
- Received
- Apr 4, 2024
- Decided
- Sep 18, 2025
- Decision
- Approved
- Supplements
- 15 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the Medtronic Altaviva System is indicated for treatment of urge urinary incontinence (UUI) in patients who failed or could not tolerate more conservative treatments.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QPT. The earliest in FDA's data is P200036, decided Mar 1, 2022.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Medtronic Neuromodulation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Restore, Itrel, Synergy, Intellis, and Vanta Spinal Cord Stimulation Systems, Pisces, Specify and Vectris Spinal Cord StPMA supplement
P840001-S469 · Decided Jan 21, 2022 · 164 days after receipt · Panel Track
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
- SureTune4 SoftwareNew device typeDe Novo
DEN210003 · Decided Aug 23, 2021 · 201 days after receipt
Device type: Brain Stimulation Programming Planning Software. (QQC) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.